Status:
COMPLETED
A Study of the Current Medical Practice and Outcomes in the Treatment of Type 2 Diabetes Mellitus in an Office Setting (MK-0431-199)
Lead Sponsor:
Merck Sharp & Dohme LLC
Conditions:
Type 2 Diabetes Mellitus
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this study is to collect information of the risk profile of patients with type 2 diabetes mellitus, their treatment concerning meeting the guidelines for treatment of diabetic patients ...
Eligibility Criteria
Inclusion
- \- Newly diagnosed with Type 2 diabetes in whom treatment with metformin in
- the individual maximal tolerated dose (at least four weeks on stable dose) resulted in
- HbA1c \>6.5%
- \- No contraindication or intolerability to metformin
Exclusion
- \- Currently being administered a combination therapy for the treatment of their Type 2 diabetes
Key Trial Info
Start Date :
August 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2011
Estimated Enrollment :
1523 Patients enrolled
Trial Details
Trial ID
NCT01409213
Start Date
August 1 2009
End Date
January 1 2011
Last Update
August 27 2015
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.